Burkhard Blank
Net worth: 2 M $ as of 2026-05-30
Net worth: 2 M $ as of 2026-05-30
Burkhard Blank formerly worked at Laurantis Pharma Oy, as Chief Executive Officer from 2013 to 2014, RIEMSER Pharma GmbH, as Director, Acorda Therapeutics, Inc., as Head-Drug Safety, Acorda Therapeutics, Inc., as Chief Medical Officer, Head-Research & Development from 2016 to 2021, Mersana Therapeutics, Inc., as Head-Clinical Development & Regulatory Affairs, MannKind Corp., as Chief Medical Officer, EVP-Research & Development from 2023 to 2025, Altus Pharmaceuticals, Inc., as Chief Medical Officer & Executive Vice President from 2006 to 2009, Boehringer Ingelheim Pharmaceuticals, Inc., as SVP-Medicine & Drug Regulatory Affairs from 2001 to 2006, Pharnext SA, as Chief Medical Officer, Head-Research & Development, and Herantis Pharma Oyj, as Chief Medical Officer.
Dr. Blank received his doctorate degree from Philipps University of Marburg.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
MANNKIND CORPORATION 0.15% | 2025-07-14 | 460,791 ( 0.15% ) | 2 M $ | 2026-05-30 |
| Companies | Position | End |
|---|---|---|
| MANNKIND CORPORATION | Chief Tech/Sci/R&D Officer | 2025-05-13 |
| ACORDA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2021-11-30 |
Laurantis Pharma Oy
Laurantis Pharma Oy Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals | Chief Executive Officer | 2014-04-30 |
Altus Pharmaceuticals, Inc.
Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops therapeutic products for gastrointestinal and metabolic diseases | Chief Tech/Sci/R&D Officer | 2009-03-26 |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Corporate Officer/Principal | 2006-05-31 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 10 |
|---|---|
Acorda Therapeutics, Inc.
Acorda Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops neurology therapies | Health Technology |
MannKind Corp.
MannKind Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes therapeutic products | Health Technology |
Mersana Therapeutics, Inc.
Mersana Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures antibody drug conjugates to improve patient outcomes in multiple oncology indications | Health Technology |
RIEMSER Pharma GmbH
RIEMSER Pharma GmbH Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceutical products | Health Technology |
Altus Pharmaceuticals, Inc.
Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops therapeutic products for gastrointestinal and metabolic diseases | Health Technology |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
Philipps University of Marburg
Philipps University of Marburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharnext SA
Pharnext SA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapies for patients to treat neurodegenerative diseases | Health Technology |
Laurantis Pharma Oy
Laurantis Pharma Oy Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals | Health Technology |
Herantis Pharma Oyj
Herantis Pharma Oyj Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products to treat neurological disorders | Health Technology |
Select your edition
All financial news and data tailored to specific country editions